Procedure for isolation and purification of kaempferol-3-o-rhamnoside, a cytotoxic compound against leukemia cells, from schima wallichii (DC.) korth.

VN8002UPending Publication Date: 2026-07-01AI HOC A NANG

Patent Information

Authority / Receiving Office
VN · VN
Patent Type
Utility models
Current Assignee / Owner
AI HOC A NANG
Filing Date
2026-05-26
Publication Date
2026-07-01
Patent Text Reader

Abstract

This useful solution refers to a procedure for isolating and purifying the compound kaempterol-3-O-rhamnoside from the bark of the medicinal tree Schima wallichii (DC.) Korth., which exhibits cytotoxic activity against HL-60 leukemia cells. The process according to the solution includes the following steps: a) preparing the raw material from the bark of the medicinal plant *Euphorbia hirta*; b) extracting the powdered raw material with 70% ethanol to obtain the ethanol extract labeled VT-E; c) dissolving the VT-E extract in hot water to obtain a liquid mixture; d) partition extraction with n-hexane to obtain the n-hexane extract labeled VT-H; e) partition extraction with dichloromethane to obtain the dichloromethane extract labeled VT-DCM; f) partition extraction with ethyl acetate to obtain the ethyl acetate extract labeled VT-EA. g) Isolating the fraction containing kaempferol-3-O-rhamnoside from the VT-EA extract using silica gel column chromatography to obtain the fraction labeled VT-EA-6; h) Purifying the VT-EA-6 fraction using column chromatography to obtain the fraction labeled VT-EA-6-3; i) Purifying the VT-EA-6-3 fraction using silica gel column chromatography to obtain the kaempferol-3-O-rhamnoside compound with formula (1). The compound kaempferol-3-O-rhamnoside obtained by the utility solution procedure exhibited significant cytotoxic activity against HL60 leukemia cell line under in vitro conditions.
Need to check novelty before this filing date? Find Prior Art